Cargando…
Radiofrequency ablation in the management of primary hepatic and biliary tumors
In the United States, 80%-90% of primary hepatic tumors are hepatocellular carcinomas and 10%-15% are cholangiocarcinomas (CCA), both with high mortality rate, particularly CCA, which portends a worse prognosis. Traditional management with surgery has good outcomes in appropriately selected patients...
Autores principales: | Hendriquez, Richard, Keihanian, Tara, Goyal, Jatinder, Abraham, Rtika R, Mishra, Rajnish, Girotra, Mohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790419/ https://www.ncbi.nlm.nih.gov/pubmed/35116111 http://dx.doi.org/10.4251/wjgo.v14.i1.203 |
Ejemplares similares
-
Endoscopic radiofrequency ablation for malignant biliary obstruction
por: Jarosova, Jana, et al.
Publicado: (2021) -
Telehealth Utilization in Gastroenterology Clinics Amid the COVID-19 Pandemic: Impact on Clinical Practice and Gastroenterology Training
por: Keihanian, Tara, et al.
Publicado: (2020) -
Radiofrequency and malignant biliary strictures: An update
por: Auriemma, Francesco, et al.
Publicado: (2019) -
Management of Barrett’s esophagus with dysplasia refractory to radiofrequency ablation
por: Raphael, Kara L, et al.
Publicado: (2020) -
Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts
por: Gao, Jun, et al.
Publicado: (2017)